Skip to main page content

Dr. Ryan Eidsness, MD, FRCSC

Uczestniczy w 12 elementy

Elementy, w których Dr. Ryan Eidsness, MD, FRCSC uczestniczy

piątek 14 czerwiec, 2019

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)

niedziela 16 czerwiec, 2019

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
10:45
10:45 - 12:15 | 1 godz. 30 min.
OculoplasticsSkills Transfer Course (STC)

piątek 10 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
13:00
13:02 - 13:09 | 7 min.
Oculoplastics

Authors: Ryan Eidsness, Malshi Kurunatilake, Mussawar Iqbal. University of Saskatchewan.Author Disclosure Block: R. Eidsness: None. M. Kurunatilake: None. M. Iqbal: NoneAbstract Body:Purpose: Discuss a case of advanced Squamous cell carcinoma (SCC) involving the eyelid, conjunctiva, and orbit that responded to Cemiplimab (Libtayo)Study Design: Study design: Case Study...

piątek 20 czerwiec, 2025

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
14:05
14:07 - 14:14 | 7 min.

Author’s Name(s): Ryan Eidsness, Seyedeh Zahra (Mona) Moossavi, Alexa MateriAuthor’s Disclosure Block: Ryan Eidsness, none; Seyedeh Zahra (Mona) Moossavi, none; Alexa Materi, noneAbstract BodyPurpose: The Purpose: of this study is to present my experience with the use of topical Imiquimod 5% for periocular BCC. BCC makes up >90% of all periocular malignancies. Non-surgical management of tumors are becoming increasingly im...

Elementy, w których Dr. Ryan Eidsness, MD, FRCSC attends

piątek 16 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
8:00
8:00 - 10:00 | 2 godz.
Current Concepts

 Learning Objectives:At the end of this session, participants will be able to:Review how to apply Quality Improvement strategies to improve patient safetyBe familiar with the presentation and histology of hereditary benign intraepithelial dyskeratosis, and be able to distinguish it from other conjunctival lesions including conjunctival intraepithelial neoplasia.Des...

10:45
10:45 - 12:15 | 1 godz. 30 min.
Oculoplastics

 Learning Objectives: At the end of this session, participants will be able to: Recognize orbital imaging findings of ocular conditions and surgeriesDescribe the various medical management options for Thyroid Eye DiseaseManage infections of...

13:30
13:30 - 15:00 | 1 godz. 30 min.
Oculoplastics

 Learning Objectives: At the end of this session, participants will be able to: Integrate novel research ideas into clinical practice  Describe key research outcomes in oculoplastics CanMEDS Roles: Scholar, Medical ExpertX

15:45
15:45 - 17:15 | 1 godz. 30 min.
Oculoplastics

 Learning Objectives: At the end of this session, participants will be able to: Integrate oncological principles in the management of oculoplastics disordersCanMEDS Roles: Medical Expert, Professional

17:15
17:15 - 18:30 | 1 godz. 15 min.
Oculoplastics